![scinus](https://www.scinus.com/wp-content/uploads/2023/05/Logomark_W-e1685445383465.png)
Scinus
Read more about our Cell Expansion technology here.
Service & maintenance
Maintenance is an investment in reliable equipment, a reliable process and providing advice.
Events
Come and visit us during the international trade shows.
About Us
![scinus-blurb](https://www.scinus.com/wp-content/uploads/2023/05/Logomark_W-e1685445383465.png)
Scinus cell expansion technology
The SCINUS bioreactor NG is a closed system for the controlled cultivation of cells, supporting your R&D as well as your GMP processes.
News / Blog
Organoid Culture: The potential to revolutionize disease modeling
Organoid Culture: The potential to revolutionize disease modeling 7 Organoids have emerged as a revolutionary tool in drug discovery and clinical practice. These miniature 3D structures, cultivated from stem cells or differentiated cells, mimic the architecture and function of organs, offering a significant advancement over traditional cell culture methods. Organoids…
New Location!
New Month, New... Location! 7 Scinus Cell Expansion is moving to Zeist As of June 1st, Scinus Cell Expansion will be located at the Utrecht Science Park location in Zeist! This place provides a vibrant, dynamic and exciting place to work, where industry and academia come together. Feel free to…
Ask the Expert: Process Development Engineer Juda-El Sam on iPSC culture using the SCINUS bioreactor NG
Ask the Expert: Process Development Engineer Juda-El Sam on iPSC culture using the SCINUS bioreactor NG 7 To standardize iPSC differentiation and production to a level necessary for producing therapy grade cells, Process Development Engineer Juda-El Sam from Scinus Cell Expansion is working on developing protocols for iPSC expansion using…
iPSCs for personalized cell therapy: prospects and remaining challenges
iPSCs for personalized cell therapy: Prospects and remaining challenges 7 The unique nature of induced pluripotent stem cells (iPSCs) lies in their capability for unlimited self–renewal and programmed differentiation into virtually any adult cell types [1]. iPSC based technology holds the potential to treat a multitude of diseases and conditions,…
Scinus recognized as one of the Top Cell Therapy Companies In Europe by Life Sciences Review
Scinus Cell Expansion B.V. has been recognized as one of the Top Cell And Gene Therapy Companies In Europe by Life Sciences Review. 7 SCINUS simplifies operational procedures and significantly diminishes the overall cost of ownership.
The Potential of AI in Cell Therapy and bioreactor systems.
The Potential of AI in Cell Therapy and bioreactor systems 7 Bioprocess control and continuous process improvement are crucial for the evolving field of cell therapy development and bioreactors. Combination of the current control and optimization technologies with the latest computer-based strategies will accelerate the path forward, providing a way…
Exploring the Promise of Mesenchymal Stromal Cells (MSCs) in Cell Therapy
Exploring the Promise of Mesenchymal Stromal Cells (MSCs) in Cell Therapy A versatile and promising cell type in the field of regenerative medicine 7 Mesenchymal stromal cells (MSCs) have emerged as a versatile and promising tool in the field of regenerative medicine, offering a multitude of therapeutic possibilities. These multipotent…
Our Carboxygenator in the spotlight!
Our Carboxygenator in the spotlight! 7 Ever wondered how our carboxygenator precisely works within the SCINUS bioreactor NG? We get that question more often, so today we're excited to share the science behind it, step by step: 𝗣𝗿𝗲𝗰𝗶𝘀𝗲 𝗚𝗮𝘀 𝗖𝗼𝗻𝘁𝗿𝗼𝗹: The carboxygenator is a patented oxygenation system that's all about…
Press release – Dutch-Danish collaboration on cell therapy
Dutch-Danish collaboration between Aarhus University Hospital and Scinus Cell Expansion Developing an efficient cell therapy production platform together 7 PRESS RELEASE Bilthoven (NL)/Aarhus (DK), July 2023 Dutch-Danish collaboration on cell therapy Cell therapy, which uses cultured human cells, is a promising treatment option for a wide range of diseases. However,…
Scinus wins PRIX GALIEN medtech innovation AWARD 2022
Scinus wins PRIX GALIEN medtech innovation AWARD 2022 7 Scinus wins PRIX GALIEN medtech innovation AWARD. At the 28th presentation of the Prix Galien Nederland Awards 2022, the Prix Galien MedTech Innovation Award was presented for the 4th time. Scinus Cell Expansion - a Demcon Investment company - received the…